Nonlinear Relationship Between Interleukin-6 and NT-proBNP at Admission in Hospitalized COVID-19 Patients

Meijuan Zhang1, Zhanquan Jiao1

  • 1Department of Cardiology, Tianjin Institute of Respiratory Diseases, Tianjin Haihe Hospital, Tianjin University, Tianjin, People's Republic of China.

PubMed

Insights

This study found a nonlinear relationship between interleukin-6 (IL-6) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in COVID-19 patients. Higher IL-6 levels correlate with increased NT-proBNP, indicating cardiac strain in these individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biomarker Research

Background:

  • Elevated interleukin-6 (IL-6) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are observed in COVID-19 patients.
  • The specific relationship between IL-6 and NT-proBNP in COVID-19 requires further investigation.

Purpose of the Study:

  • To investigate the relationship between IL-6 and NT-proBNP levels in patients diagnosed with COVID-19.

Main Methods:

  • A cross-sectional study design was employed.
  • 121 consecutive COVID-19 patients were analyzed.
  • Univariate and multivariate regression analyses, including curve fitting, were performed to assess the association between IL-6 and NT-proBNP.

Main Results:

  • A nonlinear association was identified between IL-6 and NT-proBNP levels.
  • In fully adjusted models, higher IL-6 levels showed a significant association with NT-proBNP, particularly beyond an inflection point of 2.7 (β = 0.77, P = 0.016).
  • Univariate analysis indicated a significant positive association (β = 0.28, P = 0.001), though this diminished in the fully adjusted model (β = 0.09, P = 0.176).

Conclusions:

  • The study suggests a nonlinear relationship between IL-6 and NT-proBNP in COVID-19 patients.
  • Elevated IL-6 levels are associated with increased NT-proBNP, suggesting potential cardiac involvement in COVID-19 progression.
Abstract